Amrita Palriwala

Program Officer
Phone: 
+1.202.470.5719

Amrita Palriwala, Program Officer, joined Results for Development Institute in January 2009 and is working on a growing portfolio of projects on health financing and innovative mechanisms for improving R&D and access to new health technologies in developing countries.

She has professional experience in economics with the Organization for Economic Co-operation and Development, Paris where she conducted an econometric model to compare recent patterns in obesity across OECD countries as part of the Economics of Prevention project, and the Congressional Budget Office, Washington, D.C. as an analyst in the Macroeconomic Analysis Division. She also worked at The Advisory Board Company, a best practices research and consulting firm in Washington, D.C., to advise senior executives at U.S. hospitals and health care systems on strategy and operations.

Ms. Palriwala holds a Masters in Science with merit in health economics jointly from the London School of Economics and the London School of Hygiene and Tropical Medicine (2008) and a B.A. (2003) in economics from Brandeis University.

Related News

At a major launch event of the Center for Strategic International Studies’ (CSIS) Commission on Smart Global Health Policy in Washington today, a policy paper authored by R4D for the CSIS was released, addressing the future role of the U.S. government in innovative financing for health.

Millions of people are affected by so-called “diseases of the poor” in low and middle income countries. However, there are inadequate drugs, vaccines, diagnostics, and other resources to address these health challenges. Recently, a number of innovative ideas have emerged on how to address this gap, through the creation of new funding streams, incentives for scientists and biopharma companies, and changes in intellectual property arrangements and in regulatory institutions and practices.

Related Publications & Resources

The secretariat of the Health Financing Task Force at the Results for Development Institute prepared this paper for the 25th meeting of the UNAIDS Programme Coordinating Board to evaluate the impact of the global financial crisis on HIV/AIDS programs in developing countries.

As part of the Board's request to study and revise its existing eligibility criteria, certain countries currently receiving GAVI aid are expected to become ineligible. For this reason, proper and fair graduation procedures need to be established to ensure a smooth and sustainable transition to self-financing.